What does CUSIP 462260100 represent in this 13F holders report?

CUSIP 462260100 is the security identifier for IOVA - IOVANCE BIOTHERAPEUTICS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held IOVA - IOVANCE BIOTHERAPEUTICS, INC. - Common Stock in Q2 2021?

226 institutional investors reported IOVA - IOVANCE BIOTHERAPEUTICS, INC. - Common Stock for Q2 2021. Use the holders table for investor-level position and value details.

IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA)

CUSIP: 462260100

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class: Equity / Common Stock
Shares outstanding: 395,322,451
Total 13F shares: 162,111,422
Share change: +4,562,443
Total reported value: $4,215,394,735
Put/Call ratio: 39%
Price per share: $26.02
Number of holders: 226
Value change: +$75,696,267
Number of buys: 139
Number of sells: 113

Quarterly Holders Quick Answers

What is CUSIP 462260100?
CUSIP 462260100 identifies IOVA - IOVANCE BIOTHERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2021
Previous quarter: Q1 2021

Recent filing periods for CUSIP 462260100:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of IOVA - IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ARK Investment Management LLC	13F	Company	5%	19,726,650	$624,546,000	—	31 Mar 2021	13F
VANGUARD GROUP INC	13F	Company	3%	12,053,487	$381,614,000	—	31 Mar 2021	13F
FRANKLIN RESOURCES INC	13F	Company	2.3%	9,010,970	$285,288,000	—	31 Mar 2021	13F
BlackRock Finance, Inc.	13F	Company	2.3%	8,974,815	$284,140,000	—	31 Mar 2021	13F
PERCEPTIVE ADVISORS LLC	13F	Company	2.2%	8,651,785	$273,915,000	—	31 Mar 2021	13F
Avoro Capital Advisors LLC	13F	Company	2%	8,000,000	$253,280,000	—	31 Mar 2021	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	1.8%	7,247,657	$229,460,000	—	31 Mar 2021	13F
ORBIMED ADVISORS LLC	13F	Company	1.7%	6,645,100	$210,384,000	—	31 Mar 2021	13F
Amova Asset Management Americas, Inc.	13F	Company	1.4%	5,345,861	$169,250,000	—	31 Mar 2021	13F
Sumitomo Mitsui Trust Group, Inc.	13F	Company	1.3%	5,302,733	$167,885,000	—	31 Mar 2021	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	1.3%	5,135,456	$162,589,000	—	31 Mar 2021	13F
FARALLON CAPITAL MANAGEMENT LLC	13F	Company	1.2%	4,750,000	$150,385,000	—	31 Mar 2021	13F
DEUTSCHE BANK AG\	13F	Company	1.1%	4,418,284	$139,883,000	—	31 Mar 2021	13F
STATE STREET CORP	13F	Company	0.78%	3,075,651	$97,375,000	—	31 Mar 2021	13F
Artisan Partners Limited Partnership	13F	Company	0.75%	2,983,114	$94,445,000	—	31 Mar 2021	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.66%	2,606,344	$82,516,000	—	31 Mar 2021	13F
CREDIT SUISSE AG/	13F	Company	0.61%	2,394,489	$75,809,000	—	31 Mar 2021	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.6%	2,375,814	$75,218,000	—	31 Mar 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.49%	1,917,509	$60,709,000	—	31 Mar 2021	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.48%	1,900,190	$60,160,000	—	31 Mar 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.44%	1,722,823	$54,544,000	—	31 Mar 2021	13F
Bank of New York Mellon Corp	13F	Company	0.38%	1,508,572	$47,760,000	—	31 Mar 2021	13F
JPMORGAN CHASE & CO	13F	Company	0.34%	1,342,809	$42,514,000	—	31 Mar 2021	13F
FRAZIER MANAGEMENT LLC	13F	Company	0.33%	1,312,999	$41,570,000	—	31 Mar 2021	13F
NORGES BANK	13F	Company	0.31%	1,224,416	$38,765,000	—	31 Mar 2021	13F
Invesco Ltd.	13F	Company	0.3%	1,167,872	$36,975,000	—	31 Mar 2021	13F
LORD, ABBETT & CO. LLC	13F	Company	0.28%	1,097,031	$34,732,000	—	31 Mar 2021	13F
FMR LLC	13F	Company	0.25%	973,370	$30,817,000	—	31 Mar 2021	13F
GREAT POINT PARTNERS LLC	13F	Company	0.24%	930,000	$29,444,000	—	31 Mar 2021	13F
S.c.a. Candriam	13F	Individual	0.15%	592,037	$26,387,000	—	31 Mar 2021	13F
Consonance Capital Management LP	13F	Company	0.2%	790,197	$25,018,000	—	31 Mar 2021	13F
BROWN ADVISORY INC	13F	Company	0.19%	757,621	$23,986,000	—	31 Mar 2021	13F
CITADEL ADVISORS LLC	13F	Company	0.19%	755,719	$23,926,000	—	31 Mar 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.18%	708,658	$22,437,000	—	31 Mar 2021	13F
RICE HALL JAMES & ASSOCIATES, LLC	13F	Company	0.18%	705,927	$22,350,000	—	31 Mar 2021	13F
NORTHERN TRUST CORP	13F	Company	0.17%	675,709	$21,392,000	—	31 Mar 2021	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.16%	642,032	$20,327,000	—	31 Mar 2021	13F
Nuveen Asset Management, LLC	13F	Company	0.16%	615,058	$19,473,000	—	31 Mar 2021	13F
QVT Financial LP	13F	Company	0.15%	589,516	$18,664,000	—	31 Mar 2021	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.15%	580,977	$18,394,000	—	31 Mar 2021	13F
Fairmount Funds Management LLC	13F	Company	0.14%	565,890	$17,916,000	—	31 Mar 2021	13F
MORGAN STANLEY	13F	Company	0.14%	553,314	$17,517,000	—	31 Mar 2021	13F
Tekla Capital Management LLC	13F	Company	0.13%	520,595	$16,482,000	—	31 Mar 2021	13F
ROTHSCHILD & CO ASSET MANAGEMENT US INC.	13F	Company	0.13%	518,536	$16,417,000	—	31 Mar 2021	13F
Ghost Tree Capital, LLC	13F	Company	0.13%	500,000	$15,830,000	—	31 Mar 2021	13F
Novo Holdings A/S	13F	Company	0.12%	461,811	$14,621,000	—	31 Mar 2021	13F
Hood River Capital Management LLC	13F	Company	0.12%	460,679	$14,585,000	—	31 Mar 2021	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.11%	454,323	$14,384,000	—	31 Mar 2021	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.11%	418,872	$13,261,000	—	31 Mar 2021	13F
Ally Bridge Group (NY) LLC	13F	Company	0.1%	406,986	$12,885,000	—	31 Mar 2021	13F

Institutional Holders of IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) as of Q2 2021

As of 30 Jun 2021, IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) was held by 226 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 162,111,422 shares. The largest 10 holders included ARK Investment Management LLC, VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, Avoro Capital Advisors LLC, Sumitomo Mitsui Trust Holdings, Inc., Nikko Asset Management Americas, Inc., WELLINGTON MANAGEMENT GROUP LLP, FRANKLIN RESOURCES INC, BlackRock Inc., and ORBIMED ADVISORS LLC. This page lists 227 institutional shareholders reporting positions in this security for the Q2 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders

240

Q2 2021 holders

226

Holder diff

-14

Investor	Q1 2021 Shares	Q2 2021 Shares	Share Diff	Share Chg %	Q1 2021 Value $	Q2 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.